background
rhinovirusinduc
wheez
import
risk
factor
recurr
wheez
random
control
trial
effect
system
corticosteroid
patient
diseas
object
sought
studi
shortand
longterm
effect
prednisolon
treatment
first
acut
moderatetosever
rhinovirusinduc
wheez
episod
young
children
method
confirm
rhinoviru
nasopharyng
aspir
use
pcr
children
first
wheez
episod
age
month
random
receiv
oral
prednisolon
first
dose
mgkg
follow
mgkgd
divid
dose
day
placebo
trial
doubl
blind
throughout
followup
primari
outcom
long
term
new
physicianconfirm
wheez
episod
within
month
number
physicianconfirm
wheez
episod
within
month
initi
regular
control
medic
asthma
symptom
within
month
primari
interact
analysi
examin
rhinoviru
load
result
seventyfour
patient
complet
studi
mean
age
month
atop
longterm
outcom
differ
group
p
shortterm
outcom
prednisolon
group
less
cough
rhiniti
noisi
breath
sever
breath
difficulti
nocturn
respiratori
symptom
home
within
week
p
children
greater
rhinoviru
copiesml
sensit
cutoff
benefit
prednisolon
term
less
risk
physicianconfirm
recurr
within
month
compar
placebo
p
conclus
prednisolon
routin
recommend
young
children
experienc
first
acut
moderatetosever
rhinovirusinduc
wheez
episod
prednisolon
might
benefici
subgroup
children
high
viral
load
j
allergi
clin
immunol
rhinoviru
detect
wheez
children
first
year
life
hospit
emerg
care
set
rhinovirusrel
caus
earli
wheez
particular
interest
strong
associ
odd
ratio
earli
life
recurr
wheez
doctordiagnos
asthma
year
age
suggest
explan
strike
associ
low
interferon
respons
ie
impair
viral
defens
earli
airway
inflamm
ie
broken
epitheli
barrier
genet
variat
locu
rhinovirusaffect
children
ie
might
markedli
increas
risk
asthma
overal
random
control
trial
rct
efficaci
system
corticosteroid
treatment
earli
wheez
report
clinic
efficaci
virusspecif
rct
respiratori
syncyti
viru
rsv
induc
lower
airway
ill
focus
bronchiol
found
efficaci
system
corticosteroid
previous
vinku
studi
report
post
hoc
analysi
rct
data
show
oral
prednisolon
first
wheez
episod
rhinovirusrel
caus
andor
eczema
reduc
risk
recurr
wheez
next
month
month
year
although
prior
studi
identifi
subgroup
young
wheez
children
benefit
system
corticosteroid
focus
rhinoviru
caus
high
asthma
risk
associ
rhinovirusinduc
wheez
episod
earlier
result
led
us
perform
current
rct
effect
system
corticosteroid
patient
first
rhinovirusinduc
wheez
episod
hypothes
prednisolon
decreas
risk
relaps
children
first
rhinovirusinduc
wheez
episod
recruit
trial
carri
turku
univers
hospit
june
march
vinku
mean
wheez
finnish
inclus
criteria
age
month
deliveri
gestat
abbrevi
use
hr
hazard
ratio
rct
random
control
trial
rsv
respiratori
syncyti
viru
week
later
first
wheez
episod
base
parent
report
confirm
medic
record
rhinoviru
detect
nasopharyng
aspir
sampl
use
pcr
ongo
sign
lower
respiratori
tract
symptom
cough
noisi
breath
wheez
time
pcr
result
avail
written
inform
consent
parent
guardian
exclus
criteria
presenc
chronic
nonatop
ill
previou
system
inhal
corticosteroid
treatment
particip
anoth
studi
exclud
longterm
followup
studi
childhood
varicella
contact
patient
without
previou
varicella
ill
need
intens
care
unit
treatment
poor
understand
finnish
fig
studi
commenc
obtain
written
inform
consent
parent
studi
protocol
approv
ethic
committe
turku
univers
hospit
studi
entri
guardian
fill
standard
questionnair
host
environment
risk
factor
asthma
child
physic
examin
nasopharyng
aspir
sampl
obtain
viral
diagnost
use
standard
procedur
baselin
blood
sampl
drawn
randomli
assign
studi
drug
prednisolon
vs
placebo
initi
soon
possibl
rhinovirusposit
children
studi
physician
child
still
fulfil
studi
criteria
followup
period
guardian
ask
fill
symptom
medic
diari
bring
child
studi
physician
time
child
breath
difficulti
schedul
followup
visit
arrang
week
month
month
studi
physician
studi
protocol
regist
clinicaltrialsgov
august
clinicaltri
gov
number
detail
protocol
see
method
section
fig
articl
onlin
repositori
www
jacionlineorg
subject
random
receiv
either
oral
prednisolon
first
dose
mgkg
follow
mgkgd
divid
dose
day
maximum
mgday
prednisolon
tablet
placebo
provid
leira
takeda
helsinki
finland
doubleblind
rct
design
use
detail
see
method
section
articl
onlin
repositori
wheez
refer
expiratori
breath
difficulti
highpitch
sound
expir
refer
concomit
presenc
rhinoviru
detect
mean
pcr
rhinovirusinduc
wheez
episod
posit
link
sever
respiratori
symptom
specif
rhinoviru
genotyp
show
case
rel
short
shed
gener
week
dualrhinoviru
genotyp
detect
rare
rhinoviru
detect
associ
immun
respons
vivo
rhinoviru
abl
infect
lower
airway
atopi
defin
posit
ige
antibodi
result
kul
follow
allergen
codfish
cow
milk
egg
peanut
soybean
wheat
cat
dog
hors
birch
mugwort
timothi
grass
cladosporium
herbarum
dermatophagoid
pteronyssinu
phadiatop
combi
phadia
uppsala
sweden
aeroallergen
sensit
defin
posit
ige
antibodi
latter
allergen
perenni
aeroallergen
sensit
defin
posit
ige
antibodi
result
dog
cat
pteronyssinu
birch
mugwort
timothi
grass
c
herbarum
consid
season
aeroallergen
atop
eczema
defin
physician
diagnosi
eczema
accord
typic
symptom
includ
pruritu
typic
morpholog
chronic
diseas
eczema
defin
atop
eczema
child
atop
detail
see
method
section
articl
onlin
repositori
rhinoviru
speci
b
c
enterovirus
rsv
b
detect
use
inhous
revers
transcriptas
pcr
viru
diagnost
laboratori
depart
virolog
univers
turku
nasal
swab
nylon
flock
dri
swab
copan
brescia
itali
dip
nasopharyng
aspir
store
analysi
swab
dilut
ml
pb
analyz
viral
load
ie
copi
number
multiplex
pcr
test
seeplex
ace
detect
seegen
seoul
korea
use
detect
rhinoviru
b
rsv
b
parainfluenza
viru
type
human
metapneumoviru
adenoviru
coronaviru
influenza
b
viru
frozen
sampl
human
analyz
use
pcr
serolog
previous
describ
blood
eosinophil
count
serum
level
allergenspecif
ige
analyz
use
routin
diagnost
procedur
central
laboratori
turku
univers
hospit
serum
measur
done
mean
liquid
chromatographytandem
mass
spectrometri
massachusett
gener
hospit
boston
mass
detail
see
method
section
articl
onlin
repositori
primari
outcom
occurr
new
physicianconfirm
wheez
episod
followup
number
physicianconfirm
wheez
episod
followup
initi
regular
control
medic
asthma
symptom
followup
regular
medic
initi
accord
guidelin
initi
daili
longterm
control
therapi
children
rhinoviru
load
primari
interact
analysi
investig
whether
effect
prednisolon
compar
placebo
primari
outcom
depend
rhinoviru
copi
number
secondari
outcom
includ
occurr
sever
respiratori
symptom
cough
expiratori
breath
difficulti
noisi
breath
rhiniti
nocturn
waken
breath
difficulti
scale
medic
unschedul
doctor
appoint
record
parent
daili
symptom
diari
within
month
discharg
outpati
clinic
visit
hospit
oral
corticosteroid
cours
initi
inhal
corticosteroid
wheez
also
record
exploratori
outcom
decid
extend
time
new
physicianconfirm
wheez
episod
followup
doubleblind
design
accord
previou
rct
sampl
size
children
would
suffici
power
type
error
rate
detect
absolut
differ
relaps
rate
prednisolon
placebo
within
month
rhinovirusinduc
first
wheez
episod
followup
time
month
ie
month
longer
current
studi
increas
risk
dropout
recruit
children
baselin
differ
group
analyz
use
test
normal
distribut
wilcoxon
rank
sum
test
nonnorm
distribut
continu
variabl
categor
variabl
analyz
use
x
fisher
exact
test
differ
prednisolon
placebo
group
primari
outcom
new
physicianconfirm
wheez
episod
within
month
initi
regular
control
medic
asthma
symptom
within
month
test
cox
regress
time
event
defin
baselin
time
occurr
event
surviv
time
censor
event
occur
within
month
wheez
episod
month
asthma
symptom
followup
poisson
regress
analysi
use
investig
differ
prednisolon
placebo
group
number
physicianconfirm
wheez
episod
within
month
modifi
effect
rhinoviru
load
studi
entri
effect
prednisolon
vs
placebo
test
includ
rhinoviru
loadgroup
interact
effect
cox
poisson
model
highli
posit
skew
distribut
rhinoviru
load
dichotom
cutoff
rhinoviru
load
identifi
test
differ
valu
select
approxim
threshold
yield
lowest
p
valu
rhinoviru
loadgroup
interact
effect
cox
poisson
regress
model
includ
covari
statist
signific
differ
baselin
characterist
found
group
proport
hazard
assumpt
cox
model
check
use
martingal
residu
test
cough
noisi
breath
wilcoxon
rank
sum
test
hodgeslehmann
estim
median
differ
expiratori
breath
difficulti
nocturn
symptom
bronchodil
home
poisson
regress
nocturn
symptom
outpati
clinic
visit
hospit
oral
corticosteroid
inhal
corticosteroid
use
evalu
differ
secondari
outcom
group
statist
analys
test
use
signific
level
set
use
sasstat
version
softwar
sa
system
window
sa
institut
cari
nc
enrol
studi
subject
shown
fig
sampl
inpati
outpati
rhinoviru
posit
patient
random
use
separ
list
patient
abl
take
least
half
cours
studi
drug
followup
children
prednisolon
group
none
placebo
group
drop
yield
analyt
sampl
patient
inpati
outpati
baselin
characterist
shown
tabl
detail
pleas
see
result
section
tabl
articl
onlin
repositori
wwwjacionlineorg
medic
record
subject
review
entir
studi
period
addit
symptom
diari
review
return
subject
followup
subject
followup
subject
followup
first
recurr
seen
studi
clinic
otherwis
recurr
confirm
medic
record
median
respiratori
symptom
score
first
physicianconfirm
recurr
interquartil
rang
children
recurr
expiratori
breath
difficulti
prednisolon
placebo
group
differ
primari
outcom
occurr
new
physicianconfirm
wheez
episod
within
month
p
number
physicianconfirm
wheez
episod
within
month
p
initi
regular
control
medic
asthma
symptom
within
month
p
fig
tabl
ii
rhinoviru
load
studi
entri
modifi
effect
randomli
assign
intervent
occurr
physicianconfirm
new
wheez
episod
followup
rhinoviru
load
analyz
dichotom
variabl
use
differ
cutoff
valu
tabl
iii
lowest
p
valu
interact
studi
drug
rhinoviru
load
found
cutoff
valu
copiesml
p
fig
tabl
iii
among
children
rhinoviru
load
greater
copiesml
occurr
physicianconfirm
new
wheez
episod
followup
lower
prednisolon
group
compar
seen
placebo
group
hazard
ratio
hr
ci
p
differ
found
randomli
assign
group
among
children
rhinoviru
load
copiesml
less
hr
ci
p
term
number
need
treat
treatment
children
rhinoviru
load
greater
copiesml
would
prevent
relaps
within
month
rhinoviru
load
studi
entri
also
modifi
effect
prednisolon
number
physicianconfirm
wheez
episod
next
month
rhinoviru
loadgroup
interact
effect
p
among
children
rhinoviru
load
greater
copiesml
number
physicianconfirm
new
wheez
episod
followup
lower
prednisolon
group
compar
seen
placebo
group
rel
risk
ci
p
differ
found
group
among
children
rhinoviru
load
copiesml
less
rel
risk
ci
p
among
children
rhinoviru
load
greater
copiesml
initi
regular
control
medic
asthma
symptom
within
month
nonsignificantli
lower
prednisolon
group
compar
seen
placebo
group
hr
ci
p
differ
found
group
among
children
rhinoviru
load
copiesml
less
hr
ci
p
detail
primari
interact
analysi
see
result
section
articl
onlin
repositori
shortterm
outcom
differ
group
tabl
iv
prednisolon
group
less
day
cough
rhiniti
noisi
breath
followup
compar
placebo
group
p
regard
sever
symptom
first
week
children
sever
expiratori
breath
difficulti
prednisolon
group
compar
children
placebo
group
p
moreov
children
night
awaken
breath
difficulti
prednisolon
group
compar
children
placebo
group
p
observ
differ
secondari
outcom
tabl
iv
extend
time
new
physicianconfirm
wheez
episod
followup
show
overal
differ
prednisolon
placebo
group
hr
ci
p
fig
howev
rhinoviru
load
studi
entri
modifi
effect
randomli
assign
valu
shown
mean
sd
median
interquartil
rang
number
percentag
subject
statist
signific
differ
found
randomli
assign
treatment
group
stratif
accord
inpati
outpati
pleas
see
tabl
assess
scale
consist
sum
degre
dyspnea
type
breath
sever
auscultatori
find
wheez
expiratoryinspiratori
time
delay
due
rhinoviru
pcr
diagnost
ige
antibodi
common
allergen
see
method
section
detail
intervent
occurr
physicianconfirm
new
wheez
episod
followup
rhinoviru
loadgroup
interact
effect
p
fig
among
children
rhinoviru
load
greater
copiesml
occurr
physicianconfirm
new
wheez
episod
followup
lower
prednisolon
group
compar
seen
placebo
group
hr
ci
p
differ
found
group
among
children
rhinoviru
load
copiesml
less
hr
ci
p
prednisolon
treatment
children
rhinoviru
load
greater
copiesml
would
prevent
recurr
within
month
differ
incid
advers
event
prednisolon
placebo
group
result
shown
clinic
signific
advers
event
report
first
random
doubleblind
placebocontrol
trial
investig
effect
prednisolon
first
acut
moderatetosever
rhinovirusinduc
wheez
episod
although
studi
support
benefici
effect
prednisolon
longterm
primari
outcom
prespecifi
interact
analysi
show
effect
prednisolon
close
link
rhinoviru
load
specif
children
rhinoviru
load
greater
copiesml
benefit
prednisolon
term
longer
time
physicianconfirm
relaps
followup
less
physicianconfirm
wheez
episod
within
month
also
tend
need
less
regular
control
medic
asthma
symptom
within
month
regard
shortterm
secondari
outcom
total
sampl
prednisolon
group
appear
benefit
less
cough
rhiniti
noisi
breath
sever
expiratori
breath
difficulti
nocturn
respiratori
symptom
home
within
week
compar
placebo
group
contrari
primari
hypothesi
prednisolon
show
overal
effect
primari
outcom
hypothesi
justifi
longterm
cohort
studi
demonstr
rhinovirusinduc
wheez
episod
import
earli
risk
factor
recurr
wheez
doctordiagnos
asthma
children
moreov
suscept
rhinovirusinduc
j
allergi
clin
immunol
volum
number
wheez
associ
mani
asthmarel
factor
allerg
sensit
eczema
increas
blood
eosinophil
count
increas
exhal
nitric
oxid
level
decreas
lung
function
ill
sever
matern
atop
asthma
increas
respons
decreas
ifnabgl
respons
airway
secret
broken
airway
epithelium
vitro
line
extens
epidemiolog
mechanist
data
post
hoc
analysi
previous
found
prednisolon
reduc
recurr
wheez
followup
children
rhinoviru
eczema
affect
firsttim
wheez
age
month
shortterm
benefit
prednisolon
observ
eg
less
respiratori
symptom
followup
line
previou
studi
previou
review
found
trial
show
benefici
effect
system
corticosteroid
shortterm
outcom
wherea
recent
research
focus
subgroup
might
benefit
role
combin
treatment
alansari
et
al
found
dexamethason
effect
decreas
time
readi
discharg
infant
bronchiol
increas
risk
asthma
determin
base
eczema
famili
histori
asthma
also
use
system
corticosteroid
effect
reduc
occurr
relaps
result
clinic
visit
followup
hospit
firstor
secondtim
wheez
children
age
month
associ
rhinoviru
infect
blood
eosinophil
count
l
greater
thu
system
corticosteroid
might
benefici
effect
shortterm
outcom
target
children
high
risk
asthma
defin
rhinoviru
posit
eczema
famili
histori
asthma
andor
increas
blood
eosinophil
count
moreov
system
corticosteroid
combin
nebul
epinephrin
borderlin
signific
reduc
need
hospit
infant
bronchiol
effect
affect
posit
rsv
statu
rhinoviru
examin
person
famili
histori
atopi
present
earli
cours
ill
sever
ill
four
studi
shown
effect
children
atop
characterist
underpow
fulli
address
atopi
issu
prednisolon
parent
initi
look
longerterm
outcom
ie
month
prednisolon
made
differ
high
rhinoviru
load
find
support
previou
trial
followup
show
longterm
effect
prednisolon
rhinovirusposit
children
firsttim
wheez
previou
studi
convent
pcr
follow
liquid
hybrid
use
rhinoviru
diagnost
current
studi
method
replac
realtim
pcr
effici
detect
rhinovirus
quantit
pcr
done
previou
studi
like
explan
effect
prednisolon
group
high
copi
number
high
rhinoviru
load
associ
sever
airway
inflamm
airway
inflamm
typic
associ
low
interferon
express
lead
decreas
viral
clearanc
increas
viru
replic
eventu
sever
airway
inflamm
epitheli
cell
cultur
broken
surfac
suscept
rhinoviru
replic
intact
surfac
agreement
previou
studi
shown
posit
associ
rhinoviru
load
ill
sever
cough
sever
regard
factor
baselin
characterist
rhinovirusaffect
particip
current
trial
previou
trial
similar
median
age
versu
year
preval
atopi
versu
mean
serum
level
versu
nmoll
index
hospit
versu
respect
although
thought
protect
acut
respiratori
tract
infect
sampl
averag
level
would
consid
suffici
base
current
intern
standard
suscept
viral
infect
appear
markedli
increas
level
less
nmoll
wheez
children
atop
characterist
eczema
might
import
firsttim
wheez
children
consid
respons
system
corticosteroid
importantli
aeroallergen
sensit
specif
risk
factor
asthma
among
wheez
children
develop
rather
slowli
usual
present
infanc
valu
shown
mean
sd
median
interquartil
rang
number
percentag
subject
data
analyz
use
test
cough
noisi
breath
wilcoxon
rank
sum
test
hodgeslehmann
estim
median
differ
expiratori
breath
difficulti
nocturn
symptom
bronchodil
home
poisson
regress
analysi
nocturn
symptom
outpati
clinic
visit
hospit
oral
corticosteroid
inhal
corticosteroid
nocturn
symptom
shown
categor
variabl
low
frequenc
symptom
rr
rel
risk
acut
expiratori
breath
difficulti
present
children
second
year
life
strength
studi
includ
random
doubleblind
placebocontrol
studi
design
followup
care
character
subject
regard
limit
recogn
studi
underpow
detect
less
absolut
differ
even
absolut
differ
relaps
rate
recent
consid
meaning
wheez
children
result
might
generaliz
outpati
subject
enrol
hospit
sampl
size
small
permit
meaning
analysi
inpati
versu
outpati
interact
delay
initi
studi
drug
current
trial
compar
previou
trial
vs
hour
respect
complet
rhinoviru
pcr
primari
outcom
time
recurr
shortterm
secondari
outcom
howev
found
associ
delay
primari
secondari
outcom
check
medic
record
interview
parent
use
standard
questionnair
confirm
previou
wheez
episod
bacteri
coinfect
investig
rhinoviru
speci
type
summari
prednisolon
treatment
routin
recommend
children
experienc
first
acut
moderatetosever
rhinovirusinduc
wheez
episod
abl
show
effect
primari
outcom
howev
result
suggest
prednisolon
treatment
benefici
subgroup
young
children
high
viral
load
present
appar
effect
prednisolon
longterm
outcom
among
children
high
rhinoviru
load
benefit
shortterm
outcom
warrant
studi
clinic
challeng
earli
identif
children
high
risk
asthma
identif
effect
intervent
reduc
respiratori
morbid
rhinovirusrel
caus
earli
wheez
promis
new
marker
highrisk
children
clearli
need
bedsid
quantit
rhinoviru
detect
test
rct
find
support
role
high
rhinoviru
load
import
marker
children
earli
pulmonari
inflamm
might
benefit
acut
treatment
prednisolon
thank
dr
liisa
saarikoski
research
nurs
ann
nurmi
assist
despit
benefit
secondari
shortterm
outcom
prednisolon
routin
recommend
children
first
acut
rhinovirusinduc
wheez
episod
affect
primari
longterm
outcom
interestingli
prednisolon
decreas
relaps
high
rhinoviru
load
suggest
earli
pulmonari
inflamm
children
hospit
staff
contact
studi
physician
elig
children
admit
emerg
depart
hospit
ward
need
hospit
decid
onduti
physician
outsid
studi
team
interview
guardian
studi
physician
ask
fill
standard
questionnair
host
environment
risk
factor
asthma
fig
nasopharyng
aspir
sampl
obtain
studi
entri
viral
diagnost
use
standard
procedur
rhinoviru
pcr
result
posit
studi
physician
notifi
immedi
telephon
consequ
studi
physician
contact
guardian
also
hospit
ward
child
still
hospit
verifi
child
symptom
everi
new
patient
examin
pm
day
per
week
hospit
patient
examin
everi
morn
studi
physician
fig
median
respiratori
symptom
score
assess
scale
daili
hospit
studi
visit
discharg
ward
patient
receiv
nebul
albuterol
need
discharg
parent
advis
use
b
agonist
need
guardian
instruct
fill
daili
symptom
medic
diari
month
first
week
also
assess
symptom
sever
grade
scale
thereaft
fill
date
expiratori
breath
difficulti
respiratori
medic
visit
health
care
provid
fig
data
collect
paper
continu
enter
electron
databas
studi
physician
complet
followup
electron
databas
doubl
check
independ
person
thereaft
studi
code
reveal
studi
protocol
check
yearli
basi
finnish
medicin
agenc
fimea
wwwfimeafi
check
site
fimea
author
may
result
trial
publish
accord
consort
statement
separ
computergener
random
sequenc
random
permut
block
use
inpati
outpati
prepar
store
hospit
pharmaci
reveal
children
complet
followup
prednisolon
placebo
provid
ident
contain
label
patient
number
placebo
tablet
packag
indistinguish
appear
activ
drug
recommend
administr
tablet
crush
tablet
mix
jelli
yogurt
studi
drug
administ
hospit
nurs
independ
studi
guardian
home
studi
drug
administr
record
followup
form
physicianconfirm
wheez
episod
score
standard
sheet
studi
clinic
consid
posit
outcom
expiratori
breath
difficulti
wheez
present
recurr
treat
outsid
studi
clinic
copi
outsid
medic
record
order
review
episod
consid
posit
outcom
expiratori
breath
difficulti
present
obtain
nasopharyng
aspir
steril
flock
swab
copan
dip
aspir
place
new
dri
tube
store
analysi
nucleic
acid
rtpcr
extract
elut
swab
pb
lysi
buffer
extract
nuclisen
easymag
autom
extractor
biom
erieux
boxtel
netherland
accord
manufactur
instruct
quantit
rtpcr
done
rhinoviru
use
known
concentr
rhinoviru
plasmid
posit
control
plasmid
gift
glyn
stanway
univers
colchest
essex
unit
kingdom
mean
age
children
month
sd
month
children
age
month
age
month
age
month
fiftyseven
children
male
allergenspecif
ige
sensit
eczema
atop
eczema
parent
asthma
viru
codetect
mean
level
nmoll
sd
nmoll
see
tabl
randomli
assign
studi
group
prednisolon
versu
placebo
differ
patient
characterist
compar
outpati
inpati
lower
oxygen
satur
median
interquartil
rang
vs
interquartil
rang
p
higher
respiratori
rate
mean
sd
vs
sd
breathsmin
p
higher
bodi
temperatur
vs
p
studi
entri
studi
group
differ
respect
use
nonstudi
medic
index
hospit
emerg
depart
visit
day
data
shown
differ
found
treatment
group
delay
prednisolon
initi
studi
entri
prednisolon
vs
placebo
mean
sd
vs
sd
hour
p
tabl
tabl
addit
delay
associ
primari
secondari
outcom
result
shown
last
month
common
cold
time
antibiot
prescript
time
report
everi
episod
expiratori
breath
difficulti
month
followup
period
one
episod
may
last
day
check
also
whether
patient
treat
sole
home
outpati
inpati
